daniel j. george, md, regarding the conclusions from the spartan study at asco gu 2018
Published 6 years ago • 74 plays • Length 1:47
Download video MP4
Download video MP3
Similar videos
-
2:03
daniel j. george, md, tells us about the results of the prosper study presented at asco gu 2018
-
1:58
daniel j. george, md, discusses the difference in mortality in the prosper and spartan trials
-
1:29
nicholas j. vogelzang, md, regarding the conclusions from the spartan trial at asco gu 2018
-
0:59
william k. oh, md, regarding the results of the prosper and spartan studies at asco gu 2018
-
0:55
daniel j. george, md, on how genomics are being incorporated into prostate cancer treatment
-
27:48
doctors on call - lower gi problems
-
26:40
doctors on call - february 2, 2023: lower gi problems
-
8:16
cycle of discovery - mass general's the one hundred 2014
-
2:07
daniel george on the future of mhspc treatment
-
2:44
eleni efstathiou, md, phd, regarding the prosper clinical trial from asco gu 2021
-
12:40
the hunter gets hunted - dr. amos daniel
-
0:47
daniel p. petrylak, md, offers opinion on the pout study presented at asco gu 2018
-
1:37
dr. daniel george on the incorporation of radium-223 in advanced prostate cancer
-
1:52
asco #gu19: poster walk with daniel george, md, on his research in prostate cancer
-
2:01
dr. george on rationale for abi race prostate cancer study
-
3:43
dr. daniel george - asco gu 2017
-
8:13
daniel george, md on precision medicine approaches in apc - part 1
-
1:48
nicholas j. vogelzang, md, outlines the results of the prosper study presented at asco gu 2018
-
1:14
maha hussain, md, facp, fasco, discusses the results of the prosper study at asco gu 2018
-
2:21
asco gu 2021 abstract - spartan: with long-term response to erleada
-
4:36
nonmetastatic crpc: considerations for apalutamide
-
1:31
spartan vs. prosper: apalutamide or enzalutamide for nmcrpc?
Clip.africa.com - Privacy-policy